Zydus receives final approval from the USFDA for Azithromycin Tablets USP, 500 mg
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture and market Azithromycin Tablets USP, 500 mg.
United States Zydus Lifesciences Drug Administration Cadila Healthcare Azithromycin Tablets Lifesciences Limited
Source: equitybulls.com